Early mortality in patients with cancer and COVID-19 infection treated with immunotherapy
Raphael J, Le B, Singh S, Blanchette P, Trudeau M, Lam M, Cheung M. BMC Cancer. 2025; 25(1):922.
Publications
Preoperative anemia and iron deficiency in elective gastrointestinal cancer surgery patients
Skorupski CP, Cheung MC, Hallet J, Kaliwal Y, Nguyen L, Pavenski K, Zuckerman JS, Lin Y. J Surg Oncol. 2024; Nov 12 [Epub ahead of print].
Healthcare utilization and costs in frail versus non-frail patients with diffuse large B-cell lymphoma
Vijenthira A, Calzavara A, Nagamuthu C, Kaliwal Y, Liu N, Blunt DN, Alibhai SM, Prica A, Cheung MC, Mozessohn L. Blood Adv. 2024; Jul 18 [Epub ahead of print].
A prognostic survival model incorporating patient-reported outcomes for transplant-ineligible patients with multiple myeloma
Mian H, Seow H, Balitsky AK, Cheung MC, Gayowsky A, Tay J, Wildes TM, McCurdy A, Visram A, Sandhu I, Sutradhar R. Oncologist. 2024; Apr 18 [Epub ahead of print].
The impact of marginalization on diffuse large B-cell lymphoma overall survival: a retrospective cohort study
Arya S, Mozessohn L, Gong I, Faught N, Liu N, Singh S, Chan K, Cheung MC. Leuk Lymphoma. 2024; Jan 24 [Epub ahead of print].
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada
Gong IY, Prica A, Ante Z, Calzavara A, Krzyzanowska MK, Singh S, Suleman A, Cheung MC, Crump M. Br J Haematol. 2023; Oct 27 [Epub ahead of print].
Mortality among patients with diffuse large B-cell lymphoma with mental disorders: a population-based study
Gong I, Cheung MC, Chan KKW, Arya S, Faught N, Calzavara A, Liu N, Odejide OO, Abel G, Kurdyak P, Raphael MJ, Kuczmarski T, Prica A, Mozessohn L. J Natl Cancer Inst. 2023; Aug 2 [Epub ahead of print].
Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario
Suleman A, Aktar SJ, Ante Z, Liu N, Chan KKW, Cheung MC, Prica . Br J Haematol. 2023; Jul 20 [Epub ahead of print].
Socioeconomic marginalization and health outcomes in newly diagnosed multiple myeloma: a population-based cohort study
Visram A, Seow H, Fiala MA, Gayowsky A, Cheung M, Davies G, Pond GR, Mian H. Am J Hematol. 2023; 98(8):E197-9. Epub 2023 May 16.
Prevalence and association of frailty with clinical outcomes in myeloproliferative neoplasms: a population-based study
Bankar A, Chan WC, Liu N, Cheung MC, Alibhai SM, Gupta V. Blood Adv. 2023; May 15 [Epub ahead of print].